referanslar

REFERANSLAR


  1. S. Hirayama,K. Terasawa,R. Rabeler, T. Hirayama,T. Inoue,Y. Tatsumi,M. Purpura,R. Jäger. The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial. 2014: JHND
  2. H. Russell Saeright et al. Adult ADHD: Evaluation and Treatment in Family Medicine.Am Fam Physician. 2000 Nov 1;62(9):2077-2086.
  3. https://www.fda.gov/media/99092/download
  4. Hirayama S et al.The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial. JNHD Volume27, Issues2 April 2014 Pages 284-291
  5. Dyall S. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci. 2015; 7: 52.
  6. Vaisman N, Pelled D. n−3 phosphatidylserine attenuated scopolamine-induced amnesia in middle-aged rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry 33 (2009) 952–959
  7. Murru E, Banni S, Carta G. Nutritional Properties of Dietary Omega-3-Enriched Phospholipids. Degenerative, and Neoplastic Diseases Volume 2013, Article ID 965417
  8. Vaisman N et al. Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n−3 fatty acids containing phospholipids. The American Journal of Clinical Nutrition, Volume 87, Issue 5, May 2008, Pages 1170–1180
  9. Simopoulos A. Essential fatty acids in health and chronic disease. The American Journal of Clinical Nutrition, Volume 70, Issue 3, September 1999, Pages 560s–569s
  10. Kidd PM. PS (PhosphatidylSerine) Nature's Brain Booster A Vital Lipid Nutrient For Memory Mood and Stress. 2005.books.google.com
  11. Cenacchi T et al. Cognitive decline in the elderly: A double- blind, placebo- controlled multicenter study on efficacy of phosphatidylserine administration. Aging Clinical and Experimental Research 1993. volume 5, pages123–133
  12. Manor I. Safety of phosphatidylserine containing omega3 fatty acids in ADHD children: A double-blind placebo-controlled trial followed by an open-label extension. European Psychiatry. 2020. Volume 28 Issue 6.